Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Liver Fibrosis and Cancer in Africa. Observational Study of Screening, Assessment and Treatment for Chronic Hepatitis B Virus Infection

NCT02129829 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02129829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02129829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Liver Fibrosis and Cancer in Africa. Observational Study of Screening, Assessment and Treatment for Chronic Hepatitis B Virus Infection
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
July 31, 2018
Enrollment
1,079 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, hepatocellular carcinoma